HEADER    CARBOHYDRATE BINDING PROTEIN            23-SEP-10   3OY8              
TITLE     CRYSTAL STRUCTURE OF HUMAN GALECTIN-1 IN COMPLEX WITH LACTOBIONIC ACID
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: GALECTIN-1;                                                
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: GAL-1, LECTIN GALACTOSIDE-BINDING SOLUBLE 1, BETA-          
COMPND   5 GALACTOSIDE-BINDING LECTIN L-14-I, LACTOSE-BINDING LECTIN 1, S-LAC   
COMPND   6 LECTIN 1, GALAPTIN, 14 KDA LECTIN, HPL, HBL, PUTATIVE MAPK-ACTIVATING
COMPND   7 PROTEIN PM12, 14 KDA LAMININ-BINDING PROTEIN, HLBP14;                
COMPND   8 ENGINEERED: YES;                                                     
COMPND   9 MOL_ID: 2;                                                           
COMPND  10 MOLECULE: GALECTIN-1;                                                
COMPND  11 CHAIN: B;                                                            
COMPND  12 SYNONYM: GAL-1, LECTIN GALACTOSIDE-BINDING SOLUBLE 1, BETA-          
COMPND  13 GALACTOSIDE-BINDING LECTIN L-14-I, LACTOSE-BINDING LECTIN 1, S-LAC   
COMPND  14 LECTIN 1, GALAPTIN, 14 KDA LECTIN, HPL, HBL, PUTATIVE MAPK-ACTIVATING
COMPND  15 PROTEIN PM12, 14 KDA LAMININ-BINDING PROTEIN, HLBP14;                
COMPND  16 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: LGALS1;                                                        
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   8 MOL_ID: 2;                                                           
SOURCE   9 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE  10 ORGANISM_COMMON: HUMAN;                                              
SOURCE  11 ORGANISM_TAXID: 9606;                                                
SOURCE  12 GENE: LGALS1;                                                        
SOURCE  13 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE  14 EXPRESSION_SYSTEM_TAXID: 562                                         
KEYWDS    CARBOHYDRATE BINDING PROTEIN, GALECTIN, LACTOBIONIC ACID              
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    H.BLANCHARD,P.M.COLLINS                                               
REVDAT   4   20-NOV-24 3OY8    1       HETSYN                                   
REVDAT   3   29-JUL-20 3OY8    1       COMPND REMARK HETNAM LINK                
REVDAT   3 2                   1       SITE   ATOM                              
REVDAT   2   08-NOV-17 3OY8    1       REMARK                                   
REVDAT   1   03-NOV-10 3OY8    0                                                
JRNL        AUTH   K.A.STANNARD,P.M.COLLINS,K.ITO,E.M.SULLIVAN,S.A.SCOTT,       
JRNL        AUTH 2 E.GABUTERO,I.DARREN GRICE,P.LOW,U.J.NILSSON,H.LEFFLER,       
JRNL        AUTH 3 H.BLANCHARD,S.J.RALPH                                        
JRNL        TITL   GALECTIN INHIBITORY DISACCHARIDES PROMOTE TUMOUR IMMUNITY IN 
JRNL        TITL 2 A BREAST CANCER MODEL                                        
JRNL        REF    CANCER LETT.                               2010              
JRNL        REFN                   ESSN 1872-7980                               
JRNL        PMID   20826047                                                     
JRNL        DOI    10.1016/J.CANLET.2010.08.005                                 
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.19 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : REFMAC 5.2.0019                                      
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN                             
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 55.81                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : NULL                           
REMARK   3   COMPLETENESS FOR RANGE        (%) : 94.6                           
REMARK   3   NUMBER OF REFLECTIONS             : 14103                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.175                           
REMARK   3   R VALUE            (WORKING SET) : 0.173                           
REMARK   3   FREE R VALUE                     : 0.226                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.100                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 752                             
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 20                           
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.19                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.25                         
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 748                          
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 69.01                        
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2090                       
REMARK   3   BIN FREE R VALUE SET COUNT          : 36                           
REMARK   3   BIN FREE R VALUE                    : 0.3050                       
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2065                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 48                                      
REMARK   3   SOLVENT ATOMS            : 139                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : NULL                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 29.69                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 1.56000                                              
REMARK   3    B22 (A**2) : -1.42000                                             
REMARK   3    B33 (A**2) : -0.14000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
REMARK   3   ESU BASED ON R VALUE                            (A): 0.264         
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.206         
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.131         
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.162         
REMARK   3                                                                      
REMARK   3 CORRELATION COEFFICIENTS.                                            
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.961                         
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.924                         
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT      
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):  2185 ; 0.007 ; 0.022       
REMARK   3   BOND LENGTHS OTHERS               (A):  NULL ;  NULL ;  NULL       
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):  2959 ; 1.051 ; 1.982       
REMARK   3   BOND ANGLES OTHERS          (DEGREES):  NULL ;  NULL ;  NULL       
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):   280 ;13.492 ; 5.214       
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):   105 ;33.288 ;25.238       
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):   331 ;13.439 ;15.000       
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):    10 ;16.390 ;15.000       
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):   328 ; 0.066 ; 0.200       
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):  1682 ; 0.004 ; 0.021       
REMARK   3   GENERAL PLANES OTHERS             (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):   705 ; 0.181 ; 0.200       
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  1438 ; 0.304 ; 0.200       
REMARK   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):   119 ; 0.115 ; 0.200       
REMARK   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):    28 ; 0.134 ; 0.200       
REMARK   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):     6 ; 0.223 ; 0.200       
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT      
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  1347 ; 3.450 ; 4.000       
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  2156 ; 5.238 ; 6.000       
REMARK   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):   838 ; 1.770 ; 2.000       
REMARK   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):   800 ; 2.658 ; 3.000       
REMARK   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT       
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS STATISTICS                                           
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL                              
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED : MASK                                                 
REMARK   3   PARAMETERS FOR MASK CALCULATION                                    
REMARK   3   VDW PROBE RADIUS   : 1.20                                          
REMARK   3   ION PROBE RADIUS   : 0.80                                          
REMARK   3   SHRINKAGE RADIUS   : 0.80                                          
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING   
REMARK   3  POSITIONS U VALUES: REFINED INDIVIDUALLY                            
REMARK   4                                                                      
REMARK   4 3OY8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-OCT-10.                  
REMARK 100 THE DEPOSITION ID IS D_1000061721.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 16-FEB-09                          
REMARK 200  TEMPERATURE           (KELVIN) : 293                                
REMARK 200  PH                             : 6.2                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : N                                  
REMARK 200  RADIATION SOURCE               : ROTATING ANODE                     
REMARK 200  BEAMLINE                       : NULL                               
REMARK 200  X-RAY GENERATOR MODEL          : MACSCIENCE                         
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418                             
REMARK 200  MONOCHROMATOR                  : OSMIC MIRRORS                      
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : BRUKER SMART 6000                  
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : SAINT                              
REMARK 200  DATA SCALING SOFTWARE          : SCALA                              
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 14888                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.190                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 56.200                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 94.6                               
REMARK 200  DATA REDUNDANCY                : NULL                               
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : 0.05100                            
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 10.0000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : NULL                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : NULL                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS            
REMARK 200 SOFTWARE USED: FOURIER SYNTHESIS                                     
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 50.39                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 4-8 MICROLITRE DROPS CONSISTING OF       
REMARK 280  EQUAL VOLUMES OF PROTEIN SOLUTION (20 MM SODIUM POTASSIUM           
REMARK 280  PHOSPHATE BUFFER, PH 7.0, AND PROTEIN AT CONCENTRATION OF 10 MG/    
REMARK 280  ML) AND RESERVOIR SOLUTION (0.2 M AMMONIUM SULPHATE, 25% W/V        
REMARK 280  POLYETHYLENE GLYCOL 4000, 0.1M SODIUM ACETATE TRIHYDRATE, PH 6.2)   
REMARK 280  , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K                   
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       22.35550            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       55.81100            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       29.28500            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       55.81100            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       22.35550            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       29.28500            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASN A  50       86.65   -154.38                                   
REMARK 500    PRO A  78       34.53    -92.53                                   
REMARK 500    ASN A 113       52.39   -107.85                                   
REMARK 500    SER B  29      143.11   -176.68                                   
REMARK 500    PHE B  77       82.61   -150.89                                   
REMARK 500    PRO B  78       33.68    -92.21                                   
REMARK 500    ASP B 125       57.30    -92.50                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 3OYW   RELATED DB: PDB                                   
DBREF  3OY8 A    1   134  UNP    P09382   LEG1_HUMAN       2    135             
DBREF  3OY8 B    1   134  UNP    P09382   LEG1_HUMAN       2    135             
SEQRES   1 A  134  ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO          
SEQRES   2 A  134  GLY GLU CSO LEU ARG VAL ARG GLY GLU VAL ALA PRO ASP          
SEQRES   3 A  134  ALA LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SER ASN          
SEQRES   4 A  134  ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS          
SEQRES   5 A  134  GLY ASP ALA ASN THR ILE VAL CYS ASN SER LYS ASP GLY          
SEQRES   6 A  134  GLY ALA TRP GLY THR GLU GLN ARG GLU ALA VAL PHE PRO          
SEQRES   7 A  134  PHE GLN PRO GLY SER VAL ALA GLU VAL CSO ILE THR PHE          
SEQRES   8 A  134  ASP GLN ALA ASN LEU THR VAL LYS LEU PRO ASP GLY TYR          
SEQRES   9 A  134  GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE          
SEQRES  10 A  134  ASN TYR MET ALA ALA ASP GLY ASP PHE LYS ILE LYS CME          
SEQRES  11 A  134  VAL ALA PHE ASP                                              
SEQRES   1 B  134  ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO          
SEQRES   2 B  134  GLY GLU CSO LEU ARG VAL ARG GLY GLU VAL ALA PRO ASP          
SEQRES   3 B  134  ALA LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SER ASN          
SEQRES   4 B  134  ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS          
SEQRES   5 B  134  GLY ASP ALA ASN THR ILE VAL CYS ASN SER LYS ASP GLY          
SEQRES   6 B  134  GLY ALA TRP GLY THR GLU GLN ARG GLU ALA VAL PHE PRO          
SEQRES   7 B  134  PHE GLN PRO GLY SER VAL ALA GLU VAL CME ILE THR PHE          
SEQRES   8 B  134  ASP GLN ALA ASN LEU THR VAL LYS LEU PRO ASP GLY TYR          
SEQRES   9 B  134  GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE          
SEQRES  10 B  134  ASN TYR MET ALA ALA ASP GLY ASP PHE LYS ILE LYS CME          
SEQRES  11 B  134  VAL ALA PHE ASP                                              
MODRES 3OY8 CSO A   16  CYS  S-HYDROXYCYSTEINE                                  
MODRES 3OY8 CSO A   88  CYS  S-HYDROXYCYSTEINE                                  
MODRES 3OY8 CME A  130  CYS  S,S-(2-HYDROXYETHYL)THIOCYSTEINE                   
MODRES 3OY8 CSO B   16  CYS  S-HYDROXYCYSTEINE                                  
MODRES 3OY8 CME B   88  CYS  S,S-(2-HYDROXYETHYL)THIOCYSTEINE                   
MODRES 3OY8 CME B  130  CYS  S,S-(2-HYDROXYETHYL)THIOCYSTEINE                   
HET    CSO  A  16       7                                                       
HET    CSO  A  88       7                                                       
HET    CME  A 130      10                                                       
HET    CSO  B  16       7                                                       
HET    CME  B  88      10                                                       
HET    CME  B 130      10                                                       
HET    GCO  C   1      13                                                       
HET    GAL  C   2      11                                                       
HET    GCO  D   1      13                                                       
HET    GAL  D   2      11                                                       
HETNAM     CSO S-HYDROXYCYSTEINE                                                
HETNAM     CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE                                 
HETNAM     GCO D-GLUCONIC ACID                                                  
HETNAM     GAL BETA-D-GALACTOPYRANOSE                                           
HETSYN     GCO GLUCONIC ACID                                                    
HETSYN     GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE                         
FORMUL   1  CSO    3(C3 H7 N O3 S)                                              
FORMUL   1  CME    3(C5 H11 N O3 S2)                                            
FORMUL   3  GCO    2(C6 H12 O7)                                                 
FORMUL   3  GAL    2(C6 H12 O6)                                                 
FORMUL   5  HOH   *139(H2 O)                                                    
HELIX    1   1 PRO A  101  GLY A  103  5                                   3    
HELIX    2   2 PRO B  101  GLY B  103  5                                   3    
SHEET    1   A12 ALA A  67  TRP A  68  0                                        
SHEET    2   A12 ASP A  54  ASP A  64 -1  N  ASP A  64   O  ALA A  67           
SHEET    3   A12 ASN A  40  ALA A  51 -1  N  ARG A  48   O  THR A  57           
SHEET    4   A12 PHE A  30  ASP A  37 -1  N  LYS A  36   O  ASN A  40           
SHEET    5   A12 ILE A 117  GLY A 124 -1  O  ALA A 121   N  ASN A  33           
SHEET    6   A12 VAL A   5  LEU A  11 -1  N  ALA A   6   O  MET A 120           
SHEET    7   A12 VAL B   5  LEU B  11 -1  O  VAL B   5   N  SER A   7           
SHEET    8   A12 ILE B 117  GLY B 124 -1  O  MET B 120   N  ALA B   6           
SHEET    9   A12 PHE B  30  ASP B  37 -1  N  ASN B  33   O  ALA B 121           
SHEET   10   A12 ASN B  40  ALA B  51 -1  O  PHE B  45   N  LEU B  32           
SHEET   11   A12 ASP B  54  ASP B  64 -1  O  THR B  57   N  ARG B  48           
SHEET   12   A12 ALA B  67  TRP B  68 -1  O  ALA B  67   N  ASP B  64           
SHEET    1   B12 GLN A  72  ARG A  73  0                                        
SHEET    2   B12 ASP A  54  ASP A  64 -1  N  CYS A  60   O  GLN A  72           
SHEET    3   B12 ASN A  40  ALA A  51 -1  N  ARG A  48   O  THR A  57           
SHEET    4   B12 PHE A  30  ASP A  37 -1  N  LYS A  36   O  ASN A  40           
SHEET    5   B12 ILE A 117  GLY A 124 -1  O  ALA A 121   N  ASN A  33           
SHEET    6   B12 VAL A   5  LEU A  11 -1  N  ALA A   6   O  MET A 120           
SHEET    7   B12 VAL B   5  LEU B  11 -1  O  VAL B   5   N  SER A   7           
SHEET    8   B12 ILE B 117  GLY B 124 -1  O  MET B 120   N  ALA B   6           
SHEET    9   B12 PHE B  30  ASP B  37 -1  N  ASN B  33   O  ALA B 121           
SHEET   10   B12 ASN B  40  ALA B  51 -1  O  PHE B  45   N  LEU B  32           
SHEET   11   B12 ASP B  54  ASP B  64 -1  O  THR B  57   N  ARG B  48           
SHEET   12   B12 GLN B  72  ARG B  73 -1  O  GLN B  72   N  CYS B  60           
SHEET    1   C10 GLU A 105  PRO A 109  0                                        
SHEET    2   C10 ASN A  95  LYS A  99 -1  N  LEU A  96   O  PHE A 108           
SHEET    3   C10 VAL A  84  PHE A  91 -1  N  CSO A  88   O  LYS A  99           
SHEET    4   C10 CSO A  16  VAL A  23 -1  N  VAL A  19   O  VAL A  87           
SHEET    5   C10 PHE A 126  ASP A 134 -1  O  ASP A 134   N  CSO A  16           
SHEET    6   C10 PHE B 126  ASP B 134 -1  O  VAL B 131   N  VAL A 131           
SHEET    7   C10 CSO B  16  VAL B  23 -1  N  ARG B  20   O  LYS B 129           
SHEET    8   C10 VAL B  84  PHE B  91 -1  O  ILE B  89   N  LEU B  17           
SHEET    9   C10 ASN B  95  LYS B  99 -1  O  LYS B  99   N  CME B  88           
SHEET   10   C10 GLU B 105  PRO B 109 -1  O  PHE B 108   N  LEU B  96           
LINK         C   GLU A  15                 N   CSO A  16     1555   1555  1.33  
LINK         C   CSO A  16                 N   LEU A  17     1555   1555  1.33  
LINK         C   VAL A  87                 N   CSO A  88     1555   1555  1.34  
LINK         C   CSO A  88                 N   ILE A  89     1555   1555  1.33  
LINK         C   LYS A 129                 N   CME A 130     1555   1555  1.33  
LINK         C   CME A 130                 N   VAL A 131     1555   1555  1.33  
LINK         C   GLU B  15                 N   CSO B  16     1555   1555  1.33  
LINK         C   CSO B  16                 N   LEU B  17     1555   1555  1.33  
LINK         C   VAL B  87                 N   CME B  88     1555   1555  1.33  
LINK         C   CME B  88                 N   ILE B  89     1555   1555  1.33  
LINK         C   LYS B 129                 N   CME B 130     1555   1555  1.33  
LINK         C   CME B 130                 N   VAL B 131     1555   1555  1.33  
LINK         O4  GCO C   1                 C1  GAL C   2     1555   1555  1.33  
LINK         O4  GCO D   1                 C1  GAL D   2     1555   1555  1.34  
CRYST1   44.711   58.570  111.622  90.00  90.00  90.00 P 21 21 21    4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.022366  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.017074  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.008959        0.00000